Voveran (diclofenac) can be administered intravenously, though it is not the most common route of administration. IV diclofenac is available in many countries and is used for short-term management of moderate to severe acute pain, particularly postoperative pain and renal colic. The typical IV dose ranges from 50–75 mg per day, usually given as a slow injection or infusion over several minutes. IV administration provides rapid onset of analgesia compared to oral formulations, making it useful in acute care settings. However, IV use should follow the same precautions as other routes: it is contraindicated in patients with NSAIDs hypersensitivity, severe renal or hepatic impairment, and high-risk cardiovascular or gastrointestinal conditions. Like all NSAIDs, IV diclofenac carries risks of gastrointestinal, cardiovascular, and renal adverse effects, and should be used at the lowest effective dose for the shortest duration necessary. In some countries, IV diclofenac availability and approval status may vary, so local regulatory guidelines and institutional protocols should be consulted before administration. The parenteral route is generally reserved for situations where oral administration is not feasible or rapid pain relief is clinically necessary.